Celltrion Pharm Inc.
068760·KOSDAQ·11 grantsAmendments merged
- Shares granted, cumulative
- 762,457shares
- Next lockup release
- D-218
- 2027-03-26
Against the share price
At the 2026-08-18 close- Shares with a reason to exercise
- 43,500 shares
- 0.10% of shares outstanding
- Sellable right now
- 43,500 shares
- 100% of the shares with a reason to exercise
- Unrealized paper gain (to the employees)
- ₩868M
Potential dilution
Shares by strike price
- ₩157,11462K shares
- ₩111,95167K shares
- ₩97,36046K shares
- ₩87,63752K shares
- ₩86,096117K shares
- ₩64,60674K shares
- ₩61,12060K shares
- ₩55,60169K shares
- ₩53,995124K shares
- ₩41,900Latest price
- ₩21,94544K shares
Below the line (strike < Latest price) sits above the strike price: 44K shares, 6% of the shares still inside their exercise window.
The paper gain on 43,500 shares sitting above the strike price — ₩868M — disappears unless they are exercised by the deadline. Among the options whose lockup has ended, this is the part whose timing is pinned down.
See every approaching deadlineOptions the share price has risen past gain a reason to be exercised and sold once the lockup ends. Filings do not show what has already been exercised or forfeited, so these figures are on a cumulative grants basis and the shares actually outstanding may be fewer.
Share price vs. strike price
A strike price is fixed on the grant date; only the share price moves. Where the price line crosses a dashed line is when that block of options first had a reason to be exercised.
- Strike ₩53,995124K shares
- Strike ₩86,096117K shares
- Strike ₩64,60674K shares
- Strike ₩55,60169K shares
Recipients by role
- Registered director5 people0%
- Unregistered officer8 people0%
- Employee64 people0%
- Other · unknown183 people100%
Sorted from the relation text written in the filings (260 recipients). Officers of affiliates and subsidiaries are counted as unregistered officers. This company reported many recipients under a lumped label such as “executives and employees”, or left the field blank, so the breakdown is limited.
Shares granted by year
Cumulative grants per recipient
71 named · 148 withheld| Recipient | Shares, cumulative | Average strike | Exercisable | Paper gain |
|---|---|---|---|---|
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — | |
| 00.0% | — | — | — |
Recipients granted less than 10 in 10,000 of total shares issued have their names withheld under the disclosure rules; they cannot be split apart, so they are grouped into one row. Rows that pack several people onto one line, such as “OOO and 6 others”, are grouped there too, with the headcount read from that text — the split between them is never disclosed, so “my share” can only be prefilled with the per-person average. Filings carry no employee number or year of birth, so people with the same name are added together as one. “Exercisable” counts shares whose lockup has already ended, and any paper gain accrues to the employees holding the options.
Grant history · lockup schedule
Exercisable shares over time
It rises on the day a lockup ends and falls on the day an exercise window closes. Options actually exercised are not subtracted, because only executives have to report them.
20261 grant · 74,000 sharesReleases 2029-03-24
- Granted2026-03-24
- Exercise starts2029-03-24
- Exercise ends2036-03-23
- Shares granted
- 74,000shares
- Strike price
- 64,606KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20251 grant · 124,000 sharesReleases 2028-03-25
- Granted2025-03-25
- Exercise starts2028-03-25
- Exercise ends2035-03-24
- Shares granted
- 124,000shares
- Strike price
- 53,995KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exercise[Amended] Report on grant of stock options
20241 grant · 67,000 sharesReleases 2027-03-26
- Granted2024-03-26
- Exercise starts2027-03-26
- Exercise ends2034-03-25
- Shares granted
- 67,000shares
- Strike price
- 111,951KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20231 grant · 117,000 shares
- Granted2023-03-28
- Exercise starts2026-03-28
- Exercise ends2033-03-27
- Shares granted
- 117,000shares
- Strike price
- 86,096KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20221 grant · 46,000 shares
- Granted2022-03-25
- Exercise starts2025-03-25
- Exercise ends2032-03-24
- Shares granted
- 46,000shares
- Strike price
- 97,360KRW
- Grant method
- New share issuance, Treasury shares, Cash settlement
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20211 grant · 62,000 shares
- Granted2021-03-26
- Exercise starts2024-03-26
- Exercise ends2031-03-25
- Shares granted
- 62,000shares
- Strike price
- 157,114KRW
- Grant method
- New share issuance
- Approved by
- Shareholders' meeting
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20201 grant · 69,000 shares
- Granted2020-03-27
- Exercise starts2023-03-27
- Exercise ends2030-03-26
- Shares granted
- 69,000shares
- Strike price
- 55,601KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting (term 20)
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20191 grant · 59,500 shares
- Granted2019-03-26
- Exercise starts2022-03-26
- Exercise ends2029-03-25
- Shares granted
- 59,500shares
- Strike price
- 61,120KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting (term 19)
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20181 grant · 52,451 shares
- Granted2018-03-27
- Exercise starts2021-03-27
- Exercise ends2028-03-26
- Shares granted
- 52,451shares
- Strike price
- 87,637KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting (term 18)
Below the strike priceShare price below the strike — no reason to exerciseReport on grant of stock options
20171 grant · 43,500 shares
- Granted2017-03-28
- Exercise starts2020-03-28
- Exercise ends2027-03-27
- Shares granted
- 43,500shares
- Strike price
- 21,945KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting (term 17)
Above the strike price₩19,955 per share₩868MReport on grant of stock options
20161 grant · 48,006 shares
- Granted2016-03-28
- Exercise starts2019-03-28
- Exercise ends2026-03-27
- Shares granted
- 48,006shares
- Strike price
- 15,210KRW
- Grant method
- New share issuance
- Approved by
- Annual shareholders' meeting (term 16)
Above the strike price₩26,690 per share₩1.3BReport on grant of stock options
Options actually exercised
These come from ownership reports filed by executives and major shareholders that give a stock option exercise as the reason. Employees have no such reporting duty, so this is not the company's total exercised volume. Reports filed for the same date at the same strike price are merged into one row, and they are not matched to the individual grants listed above.
Every figure here is parsed mechanically from the original DART filing (document.xml). “Exercise starts (estimated)” means the filing did not state an exercise period, so the date is the grant date plus two years under Article 340-2(4) of the Korean Commercial Act and may differ from the actual terms. Always read the original filing before making any decision.